Duan Yongping's MRNA Position Overview
Duan Yongping (via H&H International Investment, LLC) currently holds 83.0K shares of Moderna, Inc. (MRNA) worth $0, representing 0.00% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Duan Yongping has maintained a strategic position in MRNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 100.0K shares. Largest reduction occurred in Q1 2025, reducing 80.0K shares.
Analysis based on 13F filings available since 2013 Q2
Duan Yongping's Moderna (MRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Moderna (MRNA) Trades by Duan Yongping
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2021 | +60,000 | New Buy | 60,000 | $253.98 |
| Q1 2022 | +100,000 | Add 166.67% | 160,000 | $172.26 |
| Q1 2023 | -10,000 | Reduce 6.25% | 150,000 | $153.58 |
| Q2 2023 | -10,000 | Reduce 6.67% | 140,000 | $121.50 |
| Q3 2023 | -36,000 | Reduce 25.71% | 104,000 | $103.29 |
| Q4 2023 | +36,500 | Add 35.10% | 140,500 | $99.45 |
| Q1 2024 | +200 | Add 0.14% | 140,700 | $106.56 |
| Q3 2024 | -43,000 | Reduce 30.56% | 97,700 | $66.83 |
| Q4 2024 | +65,300 | Add 66.84% | 163,000 | $41.58 |
| Q1 2025 | -80,000 | Reduce 49.08% | 83,000 | $28.35 |
| Q2 2025 | -83,000 | Sold Out | 83,000 | $0.00 |
Duan Yongping's Moderna Investment FAQs
Duan Yongping first purchased Moderna, Inc. (MRNA) in Q4 2021, acquiring 60,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Duan Yongping has held Moderna, Inc. (MRNA) for 15 quarters since Q4 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Duan Yongping's largest addition to Moderna, Inc. (MRNA) was in Q1 2022, adding 160,000 shares worth $27.56 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q2 2025, Duan Yongping's firm, H&H International Investment, LLC, owns 83,000 shares of Moderna, Inc. (MRNA), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q2 2025 filing, Moderna, Inc. (MRNA) represents approximately 0.00% of Duan Yongping's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Duan Yongping's peak holding in Moderna, Inc. (MRNA) was 163,000 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.